Immatics
IMTX
Immatics (IMTX) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Chardan Capital | Maintained | Buy | $25.00 | May 19, 2026 |
| TD Cowen | Initiated Coverage | Buy | — | Apr 28, 2026 |
| Jefferies | Initiated Coverage | Buy | $18.00 | Mar 16, 2026 |
| Chardan Capital | Maintained | Buy | $25.00 | Nov 24, 2025 |
| Mizuho | Maintained | Outperform | $23.00 from $19.00 | Nov 19, 2025 |
| Guggenheim | Maintained | Buy | $19.00 from $16.00 | Nov 18, 2025 |
| Guggenheim | Initiated Coverage | Buy | $16.00 | Sep 18, 2025 |
| Deutsche Bank | Initiated Coverage | Buy | $10.00 | May 28, 2025 |
| Cantor Fitzgerald | Maintained | Overweight | — | Apr 1, 2025 |
| B of A Securities | Maintained | Buy | $15.00 from $16.00 | Nov 19, 2024 |
| Piper Sandler | Initiated Coverage | Overweight | $19.00 | Oct 7, 2024 |
| Cantor Fitzgerald | Maintained | Overweight | — | Sep 9, 2024 |
| Cantor Fitzgerald | Maintained | Overweight | — | Sep 5, 2024 |
| Mizuho | Maintained | Buy | $16.00 from $14.00 | May 16, 2024 |
| Cantor Fitzgerald | Initiated Coverage | Overweight | — | Nov 2, 2023 |
Frequently asked questions
What is the latest analyst rating on IMTX?
On May 19, 2026, Chardan Capital maintained Immatics at Buy with a price target of $25.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.